Concepedia

Abhijit Gadkari

AG

Statistics

Publications

45

Citations

7.6K

H-Index

33

Active since

2008

Affiliations

Regeneron (United States)(Current)

Sanofi (France)

Sanofi (United States)

Oregon Health & Science University

Oregon Medical Research Center

Abhijit Gadkari is an author at Regeneron (United States) specializing in dermatology, atopic dermatitis, and allergy.

Publications per year

2008–2025

45

Publications

45

Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

Eric L. Simpson, Thomas Bieber, Emma Guttman‐Yassky et al. · New England Journal of Medicine · 2016 · 2K citations · Full text

, , +12

Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

Andrew Blauvelt, Marjolein de Bruin‐Weller, Melinda Gooderham et al. · The Lancet · 2017 · 1.2K citations · Full text

, , +17

Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis

Eric L. Simpson, Amy S. Paller, Elaine C. Siegfried et al. · JAMA Dermatology · 2019 · 509 citations · Full text

, , +13

Atopic dermatitis in the pediatric population

Jonathan I. Silverberg, S. Barbarot, Abhijit Gadkari et al. · Annals of Allergy Asthma & Immunology · 2021 · 445 citations · Full text

, , +10

Unintentional non-adherence to chronic prescription medications: How unintentional is it really?

Abhijit Gadkari, Colleen A. McHorney · BMC Health Services Research · 2012 · 377 citations · Full text

, , +13

1–5 of 45